SCHEDULE: William Blair Discloses 1.8% Stake in Treace Medical

William Blair Investment Management, LLC has disclosed a 1.8% beneficial ownership stake in Treace Medical Concepts, Inc. as of December 31, 2025.

Summary

• William Blair Investment Management, LLC reported beneficial ownership of 1,145,498 shares of Common Stock in Treace Medical Concepts, Inc.
• This represents 1.8% of the class of securities.
• The reporting person holds sole voting power over 879,228 shares and sole dispositive power over 1,145,498 shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it is a standard disclosure of passive beneficial ownership and does not contain operational or financial performance information.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that Schedule 13G filings are routine disclosures by institutional investors holding less than 5% of a company's stock, indicating a passive investment stance. This filing reflects William Blair Investment Management's continued or updated position in Treace Medical Concepts, Inc. within the broader medical device sector.

Stakeholder Impact

• Shareholders: Provides transparency regarding institutional ownership, confirming William Blair Investment Management's passive stake.

Key Dates

Keywords

Schedule 13G, Beneficial Ownership, William Blair Investment Management, Treace Medical Concepts, Common Stock, Investment Adviser, SEC Filing